Inventor
Xiaoli Cheng
Inventor
Mountain View, CA, US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07KPeptides26%
G01NInvestigating or analysing materials by determining their chemical or physical properties21%
PatentTitleYear
10,787,490Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases202010,196,424Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases201910,035,824Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases201810,023,614Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases20189,624,268'Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases'2017Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2017–2020Patents assigned to PROTAGONIST THERAPEUTICS INC (5)· patent assignee history
2017–2020Based in Mountain View, CA, US· patent location history
2020Patents assigned to PROTAGANIST THERAPEUTICS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PROTAGONIST THERAPEUTICS INC | 5 | 2017–2020 |
| PROTAGANIST THERAPEUTICS INC | 1 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mountain View, California, US | 5 | 2017–2020 |